Jim Cramer noted that Teva Pharmaceuticals (TEVA - Get Report) cut their dividend and they're talking about pressure in U.S. generics. That's pretty interesting because that's the business that they bought from Allergan (AGN - Get Report) . People just feel like it doesn't have the oomph but they did boost the forecast.
Jim Cramer also noted that Teva is probably the weakest of the pharmaceuticals group.
Watch all of Jim Cramer's latest videos, right here: